2019
DOI: 10.1038/s41467-019-09645-5
|View full text |Cite
|
Sign up to set email alerts
|

Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL

Abstract: Cancer evolution is fueled by epigenetic as well as genetic diversity. In chronic lymphocytic leukemia (CLL), intra-tumoral DNA methylation (DNAme) heterogeneity empowers evolution. Here, to comprehensively study the epigenetic dimension of cancer evolution, we integrate DNAme analysis with histone modification mapping and single cell analyses of RNA expression and DNAme in 22 primary CLL and 13 healthy donor B lymphocyte samples. Our data reveal corrupted coherence across different layers of the CLL epigenome… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
72
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 70 publications
(75 citation statements)
references
References 69 publications
3
72
0
Order By: Relevance
“…Furthermore, we showed that DNA hypomethylation is variable within the myeloma cells of one individual and that methylation loss modifies H3K27me3 distribution across patients; we can hypothesize that H3K27me3 redistribution is heterogeneous among myeloma cells, leading to cell-to-cell epigenetic variability. Consequently, the tumoral mass in a MM patient would be composed of an admixture of myeloma cells with divergent epigenetic identities, in accordance with what has been demonstrated recently in CLL [56].…”
Section: Discussionsupporting
confidence: 85%
“…Furthermore, we showed that DNA hypomethylation is variable within the myeloma cells of one individual and that methylation loss modifies H3K27me3 distribution across patients; we can hypothesize that H3K27me3 redistribution is heterogeneous among myeloma cells, leading to cell-to-cell epigenetic variability. Consequently, the tumoral mass in a MM patient would be composed of an admixture of myeloma cells with divergent epigenetic identities, in accordance with what has been demonstrated recently in CLL [56].…”
Section: Discussionsupporting
confidence: 85%
“…Plates were stored at −80°C. Processing of samples were as described for Multiplexed single-cell RRBS ( Pastore et al, 2019 ) by the Epigenomic Core Facility of Weill Cornell Medicine. Briefly, nuclei were lysed, DNA was cut with Msp1 (Fermentas), and A-tailed DNA fragments were ligated with custom methylated adapters containing inline cell barcodes.…”
Section: Methodsmentioning
confidence: 99%
“…7,71 Several groups have evaluated the full reference epigenome of CLL, providing a genome-wide map of histone marks and three-dimensional chromatin architecture. 6,[72][73][74] Surprisingly, there was a significant variability in active regulatory regions among individual patients. This variability, and also the total number of active sites, was larger in U-CLL than in M-CLL.…”
Section: Epigenomic Landscapementioning
confidence: 98%